Arrowstreet Capital Limited Partnership Purchases 29,875 Shares of Mettler-Toledo International, Inc. $MTD

Arrowstreet Capital Limited Partnership boosted its stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD) by 41.3% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 102,240 shares of the medical instruments supplier’s stock after purchasing an additional 29,875 shares during the period. Arrowstreet Capital Limited Partnership’s holdings in Mettler-Toledo International were worth $142,542,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in the business. EverSource Wealth Advisors LLC boosted its holdings in shares of Mettler-Toledo International by 2.4% in the 3rd quarter. EverSource Wealth Advisors LLC now owns 294 shares of the medical instruments supplier’s stock valued at $361,000 after acquiring an additional 7 shares during the last quarter. Allworth Financial LP raised its position in Mettler-Toledo International by 6.1% during the third quarter. Allworth Financial LP now owns 121 shares of the medical instruments supplier’s stock worth $149,000 after acquiring an additional 7 shares during the period. Evergreen Capital Management LLC lifted its stake in shares of Mettler-Toledo International by 4.5% in the fourth quarter. Evergreen Capital Management LLC now owns 184 shares of the medical instruments supplier’s stock worth $257,000 after buying an additional 8 shares in the last quarter. Meridian Wealth Management LLC lifted its stake in shares of Mettler-Toledo International by 1.7% in the fourth quarter. Meridian Wealth Management LLC now owns 488 shares of the medical instruments supplier’s stock worth $680,000 after buying an additional 8 shares in the last quarter. Finally, Verdence Capital Advisors LLC lifted its stake in shares of Mettler-Toledo International by 2.0% in the fourth quarter. Verdence Capital Advisors LLC now owns 458 shares of the medical instruments supplier’s stock worth $639,000 after buying an additional 9 shares in the last quarter. 95.07% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the stock. Robert W. Baird decreased their price target on shares of Mettler-Toledo International from $1,445.00 to $1,194.00 and set a “neutral” rating on the stock in a research note on Monday, May 11th. Stifel Nicolaus decreased their price target on shares of Mettler-Toledo International from $1,600.00 to $1,400.00 and set a “buy” rating on the stock in a research note on Monday, May 18th. Barclays cut their price objective on shares of Mettler-Toledo International from $1,550.00 to $1,500.00 and set an “overweight” rating for the company in a research report on Tuesday, April 14th. Morgan Stanley cut their price objective on shares of Mettler-Toledo International from $1,475.00 to $1,275.00 and set an “equal weight” rating for the company in a research report on Tuesday, May 12th. Finally, Citigroup cut their price objective on shares of Mettler-Toledo International from $1,700.00 to $1,550.00 and set a “buy” rating for the company in a research report on Friday, May 8th. Six equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to data from MarketBeat, Mettler-Toledo International presently has a consensus rating of “Hold” and a consensus target price of $1,408.55.

Mettler-Toledo International Price Performance

Shares of MTD stock opened at $1,154.42 on Tuesday. The firm has a market cap of $23.33 billion, a PE ratio of 27.07, a price-to-earnings-growth ratio of 2.36 and a beta of 1.27. The company has a 50-day moving average of $1,201.73 and a two-hundred day moving average of $1,310.13. Mettler-Toledo International, Inc. has a 1-year low of $1,023.05 and a 1-year high of $1,525.17.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings data on Thursday, May 7th. The medical instruments supplier reported $8.91 EPS for the quarter, beating the consensus estimate of $8.70 by $0.21. Mettler-Toledo International had a net margin of 21.40% and a negative return on equity of 622.80%. The business had revenue of $947.13 million during the quarter, compared to analyst estimates of $943.14 million. During the same quarter last year, the firm posted $8.19 earnings per share. The business’s revenue for the quarter was up 7.2% compared to the same quarter last year. Mettler-Toledo International has set its FY 2026 guidance at 46.300-46.950 EPS and its Q2 2026 guidance at 10.700-10.850 EPS. Sell-side analysts anticipate that Mettler-Toledo International, Inc. will post 46.6 EPS for the current fiscal year.

Mettler-Toledo International Profile

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.